Blog

The Platforms and Promise of COVID-19 Vaccines

by Sabina Paglialunga, PhD - Director, Scientific Affairs, Celerion COVID-19 is a highly infectio...

Biosimilars are not an exact copy but are similar to the originally approved biological product. Fol...

The global COVID-19 pandemic has altered the mechanics of nearly every industry. For early phase cli...

by Sabina Paglialunga, PhD - Director, Scientific Affairs, Celerion SARS-CoV-2 symptoms include feve...

By Sumit Kar, Lead Scientist – Biomarkers, Celerion Cytokine biomarkers are released in the body aft...

In the therapeutic toolbox, there is a multitude of drug categories. For decades, small molecules ha...

COVID-19 Vaccines in Development COVID-19 is a respiratory illness caused by a novel coronavirus. Ac...

Biological therapies such as peptides, enzymes and antibodies have changed the face of medicine, pro...

Chronic obstructive pulmonary disease (COPD) describes a cluster of diseases linked to breathing pro...

« Previous Page